All Stories

  1. Genetic counselling in the era of next generation sequencing
  2. Heterodisomy in the GNAS locus is also a cause of pseudohypoparathyroidism type 1B (iPPSD3)
  3. Multi-locus imprinting disturbance (MLID): interim joint statement for clinical and molecular diagnosis
  4. Colonic adenomatous polyp with florid presence of monoclonal lambda Russell bodies: Case report and etiopathogenic hypothesis
  5. Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report
  6. Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune–Albright Syndrome (FD/MAS)
  7. Deficiencia de vitamina D en la edad adulta: presentación de 2 casos familiares de seudohipoparatiroidismo
  8. The Human Phenotype Ontology in 2024: phenotypes around the world
  9. Incidental finding at methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA): how to proceed?
  10. El enigma de la enfermedad de Enrique IV, rey de Castilla: ¿padeció síndrome de McCune-Albright/displasia fibrosa?
  11. C9ORF72 Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia
  12. Nutrition recommendations for patients with pseudohypoparathyroidism
  13. Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations
  14. Imprinting disorders
  15. New pathogenic variant in DLX5: New clues for a clinical spectrum from split-hand-foot malformation to fibular aplasia, tibial campomelia and oligosyndactyly
  16. Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis
  17. Frequency of de novo variants and parental mosaicism in families with inactivating PTH/PTHrP signaling disorder type 2
  18. Analysis of a large case series of fatal familial insomnia to determine tests with the highest diagnostic value
  19. First step towards a consensus strategy for multi-locus diagnostic testing of imprinting disorders
  20. Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants
  21. Blood β-Synuclein and Neurofilament Light Chain During the Course of Prion Disease
  22. Trans-acting genetic variants causing multilocus imprinting disturbance (MLID): common mechanisms and consequences
  23. Congenital cutaneous ossification
  24. Sporadic Creutzfeldt–Jakob disease with extremely long 14‐year survival period
  25. Gernutik lortutako zelula ama mesenkimalak (hUSC) pseudohipoparatiroidismoaren (PHP) terapia geniko ez-biralerako
  26. Design and Validation of a Process Based on Cationic Niosomes for Gene Delivery into Novel Urine-Derived Mesenchymal Stem Cells
  27. Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients
  28. Novel Variant in PLAG1 in a Familial Case with Silver–Russell Syndrome Suspicion
  29. Prenatal and foetal autopsy findings in glutaric aciduria type II
  30. Clinical and Molecular Description of 16 Families With Heterozygous IHH Variants
  31. Hereditary Spastic Paraplegia and Intellectual Disability: Clinicogenetic Lessons From a Family Suggesting a Dual Genetics Diagnosis
  32. Glucose and galactose malabsorption: A new case in Spain
  33. Malabsorción de glucosa y galactosa. Nuevo caso en España
  34. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes
  35. Implicaciones en pediatría del primer consenso internacional para el diagnóstico y asistencia a pacientes con pseudohipoparatiroidismo y enfermedades relacionadas
  36. Implication in Paediatrics of the First International Consensus Statement for the Diagnosis and management of pseudohypoparathyroidism and related disorders
  37. Cri-du-chat syndrome mimics Silver-Russell syndrome depending on the size of the deletion: a case report
  38. Impaired proteostasis in rare neurological diseases
  39. Head and neck manifestations of an undiagnosed McCune-Albright syndrome: clinicopathological description and literature review
  40. Craniofacial fibrous dysplasia and long-term untreated GH excess in McCune-Albright syndrome
  41. Progressive osseous heteroplasia caused by a mosaic GNAS mutation
  42. What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis
  43. Braquidactilia tipo C debida a mutación de parada en el gen GDF5
  44. Brachydactyly type C due to a nonsense mutation in the GDF5 gene
  45. The Use of Methylation-Sensitive Multiplex Ligation-Dependent Probe Amplification for Quantification of Imprinted Methylation
  46. Mutations causing acrodysostosis-2 facilitate activation of phosphodiesterase 4D3
  47. Intratumoral activating GNAS (R201C) mutation in two unrelated patients with virilizing ovarian Leydig cell tumors
  48. The p.R56* mutation in PTHLH causes variable brachydactyly type E
  49. Fe de errores de «Seudoseudohipoparatiroidismo frente a heteroplasia ósea progresiva en ausencia de historia familiar» [Med Clin (Barc). 2015;145(10):e25-e27]
  50. Erratum to “Pseudopseudohypoparathyroidism vs. progressive osseous heteroplasia in absence of family history” [Med Clin (Barc). 2015;145(10):e25–e27]
  51. Familial Progressive Hyperpigmentation, Cutaneous Mastocytosis, and Gastrointestinal Stromal Tumor as Clinical Manifestations of Mutations in the c-KIT Receptor Gene
  52. The Prevalence ofGNASDeficiency-Related Diseases in a Large Cohort of Patients Characterized by the EuroPHP Network
  53. Clinical and molecular analyses of Beckwith-Wiedemann syndrome: Comparison between spontaneous conception and assisted reproduction techniques
  54. From pseudohypoparathyroidism to inactivating PTH/PTHrP signaling disorder (iPPSD), a novel classification proposed by the European EuroPHP-network
  55. The prevalence of GNAS deficiency-related diseases in a large cohort of patients characterized by the EuroPHP network
  56. Marfan Syndrome Caused by Somatic Mosaicism in an FBN1 Splicing Mutation
  57. Síndrome de Marfan causado por mosaicismo somático de una mutación en splicing en FBN1
  58. Erratum to: Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci
  59. Genome-wide DNA methylation analysis of pseudohypoparathyroidism patients with GNAS imprinting defects
  60. Report of two novel mutations inPTHLHassociated with brachydactyly type E and literature review
  61. Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci
  62. Seudoseudohipoparatiroidismo frente a heteroplasia ósea progresiva en ausencia de historia familiar
  63. Pseudopseudohypoparathyroidism vs progressive osseous heteroplasia in absence of family history
  64. European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study
  65. Novel Microdeletions Affecting the GNAS Locus in Pseudohypoparathyroidism: Characterization of the Underlying Mechanisms
  66. Multilocus methylation defects in imprinting disorders
  67. European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study
  68. GATA4 Mutations Are a Cause of Neonatal and Childhood-Onset Diabetes
  69. Clinical utility gene card for: Transient Neonatal Diabetes Mellitus, 6q24-related
  70. Pseudohypoparathyrodism vs. tricho-rhino-phalangeal syndrome: patient reclassification
  71. Clinical, electrophysiological and magnetic resonance findings in a family with hereditary neuropathy with liability to pressure palsies caused by a novel PMP22 mutation
  72. Maternal Hypomethylation of KvDMR in a Monozygotic Male Twin Pair Discordant for Beckwith-Wiedemann Syndrome
  73. Simultaneous Hyper- and Hypomethylation at Imprinted Loci in a Subset of Patients withGNASEpimutations Underlies a Complex and Different Mechanism of Multilocus Methylation Defect in Pseudohypoparathyroidism Type 1b
  74. Disomy as the Genetic Underlying Mechanisms of Loss of Heterozigosity in SDHD-Paragangliomas
  75. Endocrine Profile and Phenotype-(Epi)Genotype Correlation in Spanish Patients with Pseudohypoparathyroidism
  76. GNAS (GNAS complex locus)
  77. Genome-Wide Allelic Methylation Analysis Reveals Disease-Specific Susceptibility to Multiple Methylation Defects in Imprinting Syndromes
  78. Brachydactyly E: isolated or as a feature of a syndrome
  79. PRKAR1AandPDE4DMutations Cause Acrodysostosis but Two Distinct Syndromes with or without GPCR-Signaling Hormone Resistance
  80. Clinical utility gene card for: Pseudohypoparathyroidism
  81. Array-based characterization of an interstitial de-novo deletion of chromosome 4q in a patient with a neuronal migration defect and hypocalcemia plus a literature review
  82. Detection of Hypomethylation Syndrome among Patients with Epigenetic Alterations at theGNASLocus
  83. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain
  84. Permanent Neonatal Diabetes Caused by Creation of an Ectopic Splice Site within the INS Gene
  85. Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: Evidence for an autosomal recessive form of PHP-Ib?
  86. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus
  87. Familial hypocalciuric hypercalcemia: new mutation in the CASR gene converting valine 697 to methionine
  88. Diferente expresividad de la mutacion Asn264LysfsX35 del gen GNAS en una familia afecta de pseudohipoparatiroidismo
  89. Neonatal Diabetes Caused by Mutations in Sulfonylurea Receptor 1: Interplay between Expression and Mg-Nucleotide Gating Defects of ATP-Sensitive Potassium Channels
  90. Constitutional mosaic genome-wide uniparental disomy due to diploidisation: an unusual cancer-predisposing mechanism
  91. Clinical characterization of a girl with trisomy 20q13.2qter and monosomy 13q33.1qter: Delineating phenotype-genotype correlations
  92. Neonatal Diabetes Caused by Mutations in Sulfonylurea Receptor 1: Interplay between Expression and Mg-Nucleotide Gating Defects of ATP-Sensitive Potassium Channels
  93. Neonatal Diabetes Caused by Mutations in Sulfonylurea Receptor 1: Interplay between Expression and Mg-Nucleotide Gating Defects of ATP-Sensitive Potassium Channels
  94. New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism
  95. Heterozygous glucokinase mutations and birth weight in Spanish children
  96. IntragenicGNASDeletion Involving Exon A/B in Pseudohypoparathyroidism Type 1A Resulting in an Apparent Loss of Exon A/B Methylation: Potential for Misdiagnosis of Pseudohypoparathyroidism Type 1B
  97. IntragenicGNASDeletion Involving Exon A/B in Pseudohypoparathyroidism Type 1A Resulting in an Apparent Loss of Exon A/B Methylation: Potential for Misdiagnosis of Pseudohypoparathyroidism Type 1B
  98. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue
  99. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis
  100. Familial Hyperinsulinism-Hyperammonemia Syndrome in a Family with Seizures: Case Report
  101. IntragenicGNASDeletion Involving Exon A/B in Pseudohypoparathyroidism Type 1A Resulting in an Apparent Loss of Exon A/B Methylation: Potential for Misdiagnosis of Pseudohypoparathyroidism Type 1B
  102. HETEROZYGOUS GLUCOKINASE MUTATIONS AND BIRTH WEIGHT IN SPANISH CHILDREN.
  103. Coexistence of two different pseudohypoparathyroidism subtypes (Ia and Ib) in the same kindred with independent Gs  coding mutations and GNAS imprinting defects
  104. Mutations inMAFAandIAPPare not a common cause of monogenic diabetes
  105. Glibenclamide treatment in relapsed transient neonatal diabetes as a result of aKCNJ11activating mutation (N48D)
  106. Two cases of deletion 2q37 associated with segregation of an unbalanced translocation 2;21: choanal atresia leading to misdiagnosis of CHARGE syndrome
  107. Genética del seudohipoparatiroidismo: bases para el consejo genético
  108. New mutation type in pseudohypoparathyroidism type Ia
  109. Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients
  110. ACTH-dependent precocious pseudopuberty in an infant with DAX1 gene mutation
  111. Association Study of 69 Genes in the Ret Pathway Identifies Low-penetrance Loci in Sporadic Medullary Thyroid Carcinoma
  112. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities
  113. Mutations in GCK and HNF-1? explain the majority of cases with clinical diagnosis of MODY in Spain
  114. Epigenetic Defects ofGNASin Patients with Pseudohypoparathyroidism and Mild Features of Albright’s Hereditary Osteodystrophy
  115. New ABCC8 Mutations in Relapsing Neonatal Diabetes and Clinical Features
  116. Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4
  117. Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: Comparison of IgG and IgA
  118. Panhypopituitarism: Genetic Versus Acquired Etiological Factors
  119. No Association of TLR2 and TLR4 Polymorphisms with Type I Diabetes Mellitus in the Basque Population
  120. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes
  121. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease
  122. Functional Study of a Novel Single Deletion in theTITF1/NKX2.1Homeobox Gene That Produces Congenital Hypothyroidism and Benign Chorea But Not Pulmonary Distress
  123. Contribution of MIC-A Polymorphism to Type 1 Diabetes Mellitus in Basques
  124. Killer Cell Immunoglobulin-Like Receptor (KIR) Genes in the Basque Population: Association Study of KIR Gene Contents With Type 1 Diabetes Mellitus
  125. Neoplasia endocrina múltiple: estudio genético
  126. Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus
  127. No Association ofINS-VNTR Genotype and IAA Autoantibodies
  128. Short CommunicationNo Evidence of Association ofCTLA4Polymorphisms with Addison's Disease
  129. 5′-Insulin Gene VNTR Polymorphism Is Specific for Type 1 Diabetes
  130. HLA-DRB1 andMICAin Autoimmunity
  131. No Association of CTLA4 Gene With Celiac Disease in the Basque Population
  132. A submicroscopic deletion of 11p13 associated with the WAGR syndrome
  133. Familial hypercalcemia and hypercalciuria: no mutations in the Ca 2+ -sensing receptor gene
  134. Analysis of Chromosome 6q in Basque Families with Type 1 Diabetes
  135. Excess Iron Storage in Patients with Type 2 Diabetes Unrelated to Primary Hemochromatosis
  136. Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop)
  137. No evidence of association of chromosome 2 q with Type I diabetes in the Basque population
  138. A case of Prader-Willi syndrome associated with mosaicism: Cytogenetic and FISH study.